| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |